Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the STIC-AVASTIN trial.

Thibault MazardCaroline MolleviEvelyne M LoyerJulie LégerRomain ChautardOlivier BouchéChristophe BorgPaul Armand-DujardinAurore BleuzenEric AssenatThierry Lecomte

Published in: Cancer imaging : the official publication of the International Cancer Imaging Society (2024)

NCT00489697, registration number of the STIC-AVASTIN trial.

Keyphrases

metastatic colorectal cancer
phase iii
study protocol
phase ii
clinical trial
open label
squamous cell carcinoma
locally advanced
radiation therapy
newly diagnosed